小干扰RNA在肝细胞癌中的作用
Feng Chen1, Wang Zhang1, Xinran Gao1
1Department of Biopharmaceutical, Shanghai Ocean University, Shanghai, 201306, China.
Journal of gastrointestinal cancer
|July 11, 2023
概括
小干扰RNA (siRNA) 为肝细胞癌 (HCC) 提供了一个有前途的基因疗法,肝癌是一种致命的肝癌. 研究正在推进有效的分子标和传递系统,以改善HCC治疗结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因治疗 基因治疗
背景情况:
- 肝细胞癌 (HCC) 是一种流行且极具致命性的肝癌.
- 目前针对HCC的治疗方法由于瘤异质性和晚期检测,往往是无效的.
- 使用小干扰RNA (siRNA) 的基因疗法为HCC治疗提供了一个有前途的途径.
研究的目的:
- 审查最近基于siRNA的HCC治疗方法的进展.
- 总结和分类HCC的已识别的治疗点.
- 为HCC.开发的各种siRNA传递系统进行分类.
主要方法:
- 对HCC.siRNA最近研究的文献综述.
- 对已识别的HCC治疗目标进行分析和分类.
- 在HCC治疗中使用的siRNA传递系统的分类.
主要成果:
- 在识别HCC中siRNA治疗的有效分子标方面取得了重大进展.
- 许多先进的传递系统已经开发出来,以提高siRNA在向HCC.的有效性.
- 该领域显示出改善治疗策略的巨大潜力.
结论:
- 基于siRNA的基因疗法是肝细胞癌的快速发展和有前途的策略.
- 对新的目标和复杂的传递系统的持续研究对于临床翻译至关重要.
- 本综述提供了对目前siRNA研究HCC的现状的全面概述.
更多相关视频
相关概念视频
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
Small interfering RNAs (siRNA)
3.6K
3.6K
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
lncRNA - Long Non-coding RNAs
8.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K


